Effect of OFA in Laparoscopic Gastrectomy

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 14, 2021

Primary Completion Date

November 15, 2022

Study Completion Date

November 15, 2022

Conditions
Postoperative Pain
Interventions
DRUG

OFA

Dexmedetomidine and lidocaine are administered during anesthesia, and opioid is not used. For induction, 1 μg/kg of Dexmedetomidine is administered over 10 minutes and 1mg/kg of lidocaine is administered intavenously (bolus). This is followed by continuous intravenous infusion of dexmedetomidine at a rate of 0.2-0.7 μg/kg/h and infusion of lidocaine at the rate of 1 mg/kg/h.

DRUG

Control

Remifentanil is infused during anesthesia, and target-controlled infusion (TCI) is performed according to the Minto model. During indcution of anestheisa, target concentration of remifentanil is set within 3-5 ng/mL. After intubation, target concentration is adjusted within the range of 2-8 ng/mL.

Trial Locations (2)

Unknown

Gangnam Severance Hospital, Seoul

Gangnam Severance Hsopital, Seoul

All Listed Sponsors
lead

Gangnam Severance Hospital

OTHER

NCT05076903 - Effect of OFA in Laparoscopic Gastrectomy | Biotech Hunter | Biotech Hunter